Cleveland Clinic Releases Fourth Installment of Annual Alzheimer’s Disease Drug Development Pipeline Report

Cleveland Clinic’s fourth annual analysis of Alzheimer’s disease drug development found that the pipeline has grown in the number and variety of agents being tested over the past year, while highlighting several advances in the field including new clinical trial designs, more detailed criteria for making a research diagnosis, and an increased use of biological … Read More

Cleveland Clinic Earns NIH Grant to Study Benefits of Exercise in People at Risk for Alzheimer’s Disease

A five-year, $8.75 million grant from the National Institute on Aging will help Cleveland Clinic researchers determine whether exercise can modify genetic risk for Alzheimer’s disease and reduce or prevent the cognitive decline commonly associated with the disease. The project, called Immunological Mechanisms Underlying Neuroprotection from Exercise in Alzheimer’s disease (IMMUNE-AD), will investigate the complex … Read More